Identification of distinct regions of 5' flanking DNA that mediate constitutive, IFN-γ, STAT1, and TGF-β-regulated expression of the class II transactivator gene

Journal of Immunology

Volumn 160, Issue 1, 1998, Pages 233-240

  Piskurich, Janet F ^a   Wang, Ying ^a   Linhoff, Michael W ^a   White, Leigh C ^a   Ting, Jenny P Y ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GAMMA INTERFERON; STAT1 PROTEIN; TRANSACTIVATOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; B LYMPHOCYTE; DNA SEQUENCE; GENE CONTROL; GENE EXPRESSION REGULATION; GENE INDUCTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; REGULATOR GENE;

B-LYMPHOCYTES; BASE SEQUENCE; CLONING, MOLECULAR; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; INTERFERON TYPE II; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; STAT1 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0031906211     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Schwartz, R. H. 1986. Immune response (Ir) genes of the murine major histocompatibility complex. Adv. Immunol. 38:31.
2. Glimcher, L. H., and C. J. Kara. 1992. Sequences and factors: a guide to MHC class-II transcription. Annu. Rev. Immunol. 10:13.
3. Ting, J. P.-Y., and A. S. Baldwin. 1993. Regulation of MHC gene expression. Curr. Opin. Immunol. 5:8.
4. Mach, B., V. Steimle, E. Martinez-Soria, and W. Reith. 1996. Regulation of MHC class II genes: lessons from a disease. Annu. Rev. Immunol. 14:301.
5. Rosa, F., D. Hatat, A. Abadie, D. Wallach, M. Revel, and M. Fellous. 1983. Differential regulation of HLA-DR mRNAs and cell surface antigens by interferon. EMBO J. 2:1585.
6. Collins, T., A. J. Korman, C. T. Wake, J. M. Boss, D. J. Kappes, W. Fiers, K. A. Ault, M. A. Gimbrone, J. L. Strominger, and J. S. Pober. 1984. Immune Interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts. Proc. Natl. Acad. Sci. USA 81:4917.
7. Basta, P. V., P. A. Sherman, and J. P.-Y. Ting. 1987. Identification of an interferon-γ response region 5′ of the human histocompatibility leukocyte antigen DRA chain gene which is active in human glioblastoma multiforme lines. J. Immunol. 138:1275.
8. Barr, C. L., and G. F. Saunders. 1991. Interferon-gamma-inducible regulation of the human invariant chain gene. J. Biol. Chem. 266:3475.
9. Sloan, J. H., S. L. Hasegawa, and J. M. Boss. 1992. Single base pair substitutions within the HLA-DRA gene promoter separate the functions of the X1 and X2 boxes. J. Immunol. 148:2591.
10. Brown, A. M., K. L. Wright, and J. P. Ting. 1993. Human major histocompatibility complex class II-associated invariant chain gene promoter: functional analysis and in vivo protein/DNA interactions of constitutive and IFN-gamma-induced expression. J. Biol. Chem. 268:26328.
11. Steimle, V., L. A. Otten, M. Zufferey, and B. Mach. 1993. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75:135.
12. Chang, C.-H., J. D. Fontes, M. Peterlin, and R. A. Flavell. 1994. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J. Exp. Med. 180:1367.
13. Chin, K.-C., C. Mao, C. Skinner, J. L. Riley, K. L. Wright, C. S. Moreno, G. R. Stark, J. M. Boss, and J. P.-Y. Ting. 1994. Molecular analysis of G1B and G3A IFNγ mutants reveals that defects in CIITA of RFX result in defective class II MHC and Ii gene induction. Immunity 1:679.
14. Steimle, V., C. A. Siegrist, A. Mottet, B. Lisowska-Grospierre, and B. Mach. 1994. Regulation of MHC class II expression by interferon-γ mediated by the transactivator gene CIITA. Science 265:106.
15. Chang, C. H., S. Guerder, S. C. Hong, W. van Ewijk, and R. A. Flavell. 1996. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity 4:167.
16. Riley, J. L., S. D. Westerheide, J. A. Price, J. A. Brown, and J. M. Boss. 1995. Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA). Immunity 2:533.
17. Zhou, H., and L. H. Glimcher. 1995. Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency. Immunity 2:545.
18. Chin, K.-C., G. G.-X. Li, and J. P.-Y. Ting. 1997. Importance of acidic, proline/serine/threonine-rich, and GTP-binding regions in the major histocompatibility complex class II transactivator: generation of transdominant-negative mutants. Proc. Natl. Acad. Sci. USA 94:2501.
19. Scholl, T., S. K. Mahanta, and J. L. Strominger. 1997. Specific complex formation between type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5. Proc. Natl. Acad. Sci. USA 94:6330.
20. Fontes, J. D., N. Jabrane-Ferrat, C. R. Toth, and B. M. Peterlin. 1996. Binding and cooperative interactions betwween two B cell-specific transcriptional coactivators. J. Exp. Med. 183:2517.
21. Lee, Y.-J., Y. Han, H.-T. Lu, V. Nguyen, H. Qin, P. H. Howe, B. A. Hocevar, J. M. Boss, R. M. Ransohoff, and E. N. Benveniste. 1997. TGF-β suppresses IFN-γ induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression. J. Immunol. 158:2065.
22. Nandan, D., and N. E. Reiner. 1997. TGF-β attenuates the class II transactivator and reveals an accessory pathway of IFN-γ action. J. Immunol. 158:1095.
23. Meraz, M. A., J. M. White, K. C. Sheehan, E. A. Bach, S. J. Rodig, A. S. Dighe, D. H. Kaplan, J. K. Riley, A. C. Greenlund, D. Campbell, K. Carver-Moore, R. N. DuBois, R. Clark, M. Aguet, and R. D. Schreiber. 1996. Targeted disruption of the Stat 1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84:431.
24. 1, gene results in multifocal inflammatory disease. Nature 359:693.
25. 1 null mouse phenotype. Proc. Natl. Acad. Sci. USA 90:9944.
26. Pellegrini, S., J. John, M. Shearer, I. M. Kerr, and G. R. Stark. 1989. Use of a selectable marker regulated by alpha interferon to obtain mutations in the signaling pathway. Mol. Cell. Biol. 9:4605.
27. Piskurich, J. F., M. H. Blanchard, K. R. Youngman, J. A. France, and C. S. Kaetzel. 1995. Molecular cloning of the mouse polymeric Ig receptor: functional regions of the molecule are conserved among five mammalian species. J. Immunol. 154:1735.
28. Malik, A. N., P. M. McLean, A. Roberts, P. S. Barnett, A. G. Demaine, J. P. Banga, and A. M. McGregor. 1990. A simple high yield method for the preparation of lambda gt10 DNA suitable for subcloning, amplification and direct sequencing. Nucleic Acids Res. 18:4031.
29. Sambrook, J., E. F. Fritsh, and T. Maniatis. 1989. Molecular Cloning. A Laboratory Manual, 2nd Ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
30. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463.
31. Wright, K. L., L. C. White, A. Kelly, S. Beck, J. Trowsdale, and J. P.-Y. Ting. 1995. Coordinate regulation of the human TAP1 and LMP2 genes from a shared bi-directional promoter. J. Exp. Med. 181:1459.
32. Improta, T., C. Schindler, C. M. Horvath, I. M. Kerr, G. R. Stark, and J. E. Darnell, Jr. 1994. Transcription factor ISGF-3 formation requires phosphorylated Stat91 protein, but Stat113 protein is phosphorylated independently of Stat91 protein. Proc. Natl. Acad. Sci. USA 91:4776.
33. Brasier, A. R., J. E. Tate, and J. F. Habener. 1989. Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines. Biotechniques 7:1116.
34. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72:248.
35. Bucher, P. 1990. Weight matrix descriptions of four eukaryotic RNA polymerase II promoter elements derived from 502 unrelated promoter sequences. J. Mol. Biol. 212:563.
36. Ihle, J. N., and I. M. Kerr. 1995. Jaks and Stats in signaling by the cytokine receptor superfamily. Trends Genet. 11:69.
37. Staudt, L. M., and M. J. Lenardo. 1991. Immunoglobulin gene transcription. Annu. Rev. Immunol. 9:373.
38. Klemsz, M. J., S. R. McKercher, A. Celada, C. Van Beveren, and R. A. Maki. 1990. The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene. Cell 61:113.
39. Panek, R. B., and E. N. Benveniste. 1995. Class II MHC gene expression in microglia: regulation by the cytokines IFN-γ, TNF-α, and TGF-β. J. Immunol. 154:2846.
40. 1 transforming growth factor in human astrocytoma cells: definition of cis-element. J. Biol. Chem. 268:18794.
41. 1 repression of the HLA-DRα gene is mediated by conserved proximal promoter elements. J. Immunol. 151:4173.
42. Darnell, J. E. J., I. M. Kerr, and G. R. Stark. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415.
43. Shuai, K., C. Schindler, V. R. Prezioso, and J. E. J. Damell. 1992. Activation of transcription by IFNγ: tyrosine phosphorylation of a 91-kD DNA binding protein. Science 258:1808.
44. Shuai, K., G. R. Stark, I. M. Kerr, and J. E. J. Darnell. 1993. A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma. Science 261:1744.
45. Lee, Y. J., and E. N. Benveniste. 1996. Stat1α expression is involved in IFN-γ induction of the class II transactivator and class II MHC genes. J. Immunol. 157:1559.
46. 1 inhibition of transin/stromelysin gene expression is mediated through a Fos binding sequence. Cell 61:267.
47. Lennon, A. M., C. Ottone, G. Rigaud, L. L. Deaven, J. Longmire, M. Fellous, R. Bono, and C. Alcaide-Loridan. 1997. Isolation of a B-cell-specific promoter for the human class II transactivator for Immunogentics 45:266.
48. Muhlethaler-Mottett, A., L. A. Otten, V. Steimle, and B. Mach. 1997. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. EMBO J. 16:2851.